A detailed history of Legacy Financial Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 5,648 shares of AMGN stock, worth $1.54 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
5,648
Previous 5,607 0.73%
Holding current value
$1.54 Million
Previous $1.75 Million 3.88%
% of portfolio
0.35%
Previous 0.35%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $12,684 - $13,832
41 Added 0.73%
5,648 $1.82 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $1,051 - $1,277
4 Added 0.07%
5,607 $1.75 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $28,231 - $34,078
105 Added 1.91%
5,603 $1.59 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $50,884 - $57,403
199 Added 3.76%
5,498 $1.58 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $116,977 - $145,231
535 Added 11.23%
5,299 $1.42 Million
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $8,356 - $9,881
39 Added 0.83%
4,764 $1.06 Million
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $63,221 - $77,056
280 Added 6.3%
4,725 $1.14 Million
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $105,811 - $134,446
462 Added 11.6%
4,445 $1.17 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $10,325 - $11,644
46 Added 1.17%
3,983 $898,000
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $85,131 - $94,737
369 Added 10.34%
3,937 $958,000
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $33,109 - $36,628
151 Added 4.42%
3,568 $863,000
Q4 2021

Feb 04, 2022

BUY
$198.88 - $227.6 $89,496 - $102,420
450 Added 15.17%
3,417 $769,000
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $17,406 - $20,393
-82 Reduced 2.69%
2,967 $631,000
Q2 2021

Jul 21, 2021

SELL
$233.58 - $259.14 $6,540 - $7,255
-28 Reduced 0.91%
3,049 $743,000
Q1 2021

Apr 28, 2021

BUY
$221.91 - $258.6 $90,317 - $105,250
407 Added 15.24%
3,077 $766,000
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $26,398 - $31,435
122 Added 4.79%
2,670 $613,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $597,888 - $664,900
2,548 New
2,548 $648,000
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $251,673 - $333,787
-1,381 Closed
0 $0
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $756 - $972
-4 Reduced 0.29%
1,381 $333,000
Q3 2019

Nov 07, 2019

BUY
$174.11 - $208.62 $7,660 - $9,179
44 Added 3.28%
1,385 $268,000
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $11,335 - $13,287
-68 Reduced 4.83%
1,341 $247,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $125,704 - $141,696
695 Added 97.34%
1,409 $268,000
Q4 2018

Jan 16, 2019

BUY
$178.4 - $208.25 $5,530 - $6,455
31 Added 4.54%
714 $139,000
Q3 2018

Oct 30, 2018

SELL
$185.29 - $208.89 $7,782 - $8,773
-42 Reduced 5.79%
683 $141,000
Q2 2018

Jul 17, 2018

BUY
$166.05 - $186.51 $6,974 - $7,833
42 Added 6.15%
725 $142,000
Q1 2018

Apr 12, 2018

BUY
$169.43 - $198.0 $3,049 - $3,564
18 Added 2.71%
683 $118,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $112,245 - $125,412
665
665 $115,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.